Skip to content
← All treatment topics

TREATMENT READING

Childhood Oral Cavity Cancer

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Health professional

Special Considerations for the Treatment of Children With Cancer

Source: Childhood Oral Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 16, 2024. Captured 2026-09-09.

Cancer in children and adolescents is rare, although the overall incidence has slowly increased since 1975.[1] Children and adolescents with cancer should be referred to medical centers that have a multidisciplinary team of cancer specialists with experience treating the cancers that occur during childhood and adolescence. This multidisciplinary team approach incorporates the skills of the following pediatric specialists and others to ensure that children receive treatment, supportive care, and rehabilitation to achieve optimal survival and quality of life:

Sources: 1

Primary care physicians.

Pediatric surgeons.

Pathologists.

Pediatric radiation oncologists.

Pediatric medical oncologists and hematologists.

Ophthalmologists.

Rehabilitation specialists.

Pediatric oncology nurses.

Social workers.

Child-life professionals.

Psychologists.

Nutritionists.

For specific information about supportive care for children and adolescents with cancer, see the summaries on Supportive and Palliative Care.

Sources: Supportive and Palliative Care

The American Academy of Pediatrics has outlined guidelines for pediatric cancer centers and their role in the treatment of children and adolescents with cancer.[2] At these centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate is offered to most patients and their families. Clinical trials for children and adolescents diagnosed with cancer are generally designed to compare potentially better therapy with current standard therapy. Other types of clinical trials test novel therapies when there is no standard therapy for a cancer diagnosis. Most of the progress in identifying curative therapies for childhood cancers has been achieved through clinical trials. Information about ongoing clinical trials is available from the NCI website.

Sources: 2 · NCI website

Dramatic improvements in survival have been achieved for children and adolescents with cancer. Between 1975 and 2020, childhood cancer mortality decreased by more than 50%.[3-5] Childhood and adolescent cancer survivors require close monitoring because side effects of cancer therapy may persist or develop months or years after treatment. For information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors, see Late Effects of Treatment for Childhood Cancer.

Sources: 3 · 5 · Late Effects of Treatment for Childhood Cancer

Childhood cancer is a rare disease, with about 15,000 cases diagnosed annually in the United States in individuals younger than 20 years.[6] The U.S. Rare Diseases Act of 2002 defines a rare disease as one that affects populations smaller than 200,000 people in the United States. Therefore, all pediatric cancers are considered rare.

Sources: 6 · Rare Diseases Act of 2002

The designation of a rare tumor is not uniform among pediatric and adult groups. In adults, rare cancers are defined as those with an annual incidence of fewer than six cases per 100,000 people. They account for up to 24% of all cancers diagnosed in the European Union and about 20% of all cancers diagnosed in the United States.[7,8] In children and adolescents, the designation of a rare tumor is not uniform among international groups, as follows:

Sources: 7 · 8

A consensus effort between the European Union Joint Action on Rare Cancers and the European Cooperative Study Group for Rare Pediatric Cancers estimated that 11% of all cancers in patients younger than 20 years could be categorized as very rare. This consensus group defined very rare cancers as those with annual incidences of fewer than two cases per 1 million people. However, three additional histologies (thyroid carcinoma, melanoma, and testicular cancer) with incidences of more than two cases per 1 million people were also included in the very rare group due to a lack of knowledge and expertise in the management of these tumors.[9]

Sources: 9

The Children's Oncology Group defines rare pediatric cancers as those listed in the International Classification of Childhood Cancer subgroup XI, which includes thyroid cancers, melanomas and nonmelanoma skin cancers, and multiple types of carcinomas (e.g., adrenocortical carcinomas, nasopharyngeal carcinomas, and most adult-type carcinomas such as breast cancers and colorectal cancers).[10] These diagnoses account for about 5% of the cancers diagnosed in children aged 0 to 14 years and about 27% of the cancers diagnosed in adolescents aged 15 to 19 years.[4] Most cancers in subgroup XI are either melanomas or thyroid cancers, with other cancer types accounting for only 2% of the cancers diagnosed in children aged 0 to 14 years and 9.3% of the cancers diagnosed in adolescents aged 15 to 19 years.

Sources: 10 · 4

These rare cancers are extremely challenging to study because of the relatively few patients with any individual diagnosis, the predominance of rare cancers in the adolescent population, and the small number of clinical trials for adolescents with rare cancers.

Information about these tumors may also be found in sources relevant to adults with cancer, such as Lip and Oral Cavity Cancer Treatment.

Sources: Lip and Oral Cavity Cancer Treatment

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional

Treatment of Childhood Oral Cavity Cancer

Source: Childhood Oral Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 16, 2024. Captured 2026-09-09.

Treatment options for childhood oral cavity cancer include the following:

Surgery.

Chemotherapy.

Radiation therapy.

The management of malignant tumors of the oral cavity depends on histology.[1] Most patients with oral cavity squamous cell carcinoma and intraoral mucoepidermoid carcinoma who were managed with surgery alone have a good prognosis and do not experience recurrences.[2-4] For more information, see Lip and Oral Cavity Cancer Treatment.

Sources: 1 · 2 · 4 · Lip and Oral Cavity Cancer Treatment

Langerhans cell histiocytosis of the oral cavity may require treatment in addition to surgery. For more information, see Langerhans Cell Histiocytosis Treatment.

Sources: Langerhans Cell Histiocytosis Treatment

Surgery is the primary treatment modality for benign oral cavity tumors.

Health professional

Treatment Options Under Clinical Evaluation for Childhood Oral Cavity Cancer

Source: Childhood Oral Cavity Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: September 16, 2024. Captured 2026-09-09.

Information about National Cancer Institute (NCI)–supported clinical trials can be found on the NCI website. For information about clinical trials sponsored by other organizations, see the ClinicalTrials.gov website.

Sources: NCI website · ClinicalTrials.gov website

For patients

Treatment of childhood oral cavity cancer

Source: Childhood Oral Cavity Cancer (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 12, 2025. Captured 2026-09-09.

There are different types of treatment for children with oral cavity cancer. You and your child's care team will work together to decide treatment. Many factors will be considered, such as where the cancer is located and your child's age and overall health.

Your child's treatment plan will include information about the cancer, the goals of treatment, treatment options, and the possible side effects. It will be helpful to talk with your child's care team before treatment begins about what to expect. For help every step of the way, see our booklet, Children with Cancer: A Guide for Parents.

Sources: Children with Cancer: A Guide for Parents

For oral cavity cancer in children, treatment might include:

Surgery is the most common treatment for oral cavity cancer in children. For children with an oral cavity tumor that is not cancer, surgery is likely the only treatment that will be needed. Learn more about Surgery to Treat Cancer.

Sources: Surgery to Treat Cancer

Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy may be given with other types of treatments.Chemotherapy can be given in different ways. For oral cavity cancer, chemotherapy is injected into a vein, enabling it to reach cancer cells throughout the body. Learn more about Chemotherapy to Treat Cancer.

Sources: Chemotherapy to Treat Cancer

Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. The type of radiation therapy most often used for oral cavity cancer is external beam radiation therapy. This treatment uses a machine outside the body to send radiation toward the area of the body with cancer. Learn more about External Beam Radiation Therapy for Cancer and Radiation Therapy Side Effects.

Sources: External Beam Radiation Therapy for Cancer · Radiation Therapy Side Effects

Disease and treatment settings

Childhood Oral Cavity Cancer

Disease and treatment setting

Oral Cavity Cancer in children and adolescents